Assay Principle

Lactate Dehydrogenase (LDH; EC 1.1.1.27) is a cytoplasmic enzyme present in virtually all cells that catalyzes the reversible interconversion of lactate and pyruvate with concomitant reduction or oxidation of the coenzyme NAD⁺/NADH. Elevated LDH activity in extracellular media or biological fluids is a widely used indicator of cell membrane damage and cytotoxicity.

In this DNPH-based micro method, the assay proceeds in two steps:

1. Enzymatic reaction: LDH in the sample oxidizes L-lactate to pyruvate using NAD⁺ as the electron acceptor, generating NADH.
2. Colorimetric detection: Pyruvate produced in the enzymatic reaction reacts with 2,4-dinitrophenylhydrazine (DNPH) under acidic conditions to form pyruvate-2,4-dinitrophenylhydrazone, a brown-colored complex. Upon alkalinization, this hydrazone develops a stable color with maximum absorbance at 440 nm, and its optical density is directly proportional to pyruvate concentration and, consequently, LDH activity.

This micro-scale format minimizes sample consumption while maintaining analytical sensitivity, making it suitable for precious or low-volume specimens.

Materials and Reagents

Provided in the Kit (L1524120):

• Substrate Buffer (containing L-lactate and NAD⁺)
• DNPH Reagent (2,4-dinitrophenylhydrazine solution)
• NaOH Solution (for color development)
• Pyruvate Standard Solution (for standard curve preparation)
• Assay Buffer

Required but Not Provided:

• Microcentrifuge and tubes
• Micropipettes and tips (2–200 µL range)
• 96-well microplate or cuvettes
• Spectrophotometer or microplate reader capable of measuring absorbance at 440 nm
• Incubator or water bath set to 37 °C
• Ice bucket
• Phosphate-buffered saline (PBS) or appropriate lysis buffer for sample preparation

Sample Storage: Keep samples on ice during preparation. Avoid repeated freeze-thaw cycles, which may reduce LDH activity. Process samples promptly or store at −80 °C.

Step-by-Step Assay Procedure

1. Sample Preparation

• For cell lysates: wash cells with PBS, lyse with appropriate lysis buffer, centrifuge at 600–1000 × g for 5 min at 4 °C, and collect the supernatant.
• For tissue homogenates: homogenize tissue in cold assay buffer (weight-to-volume ratio of approximately 1:9), centrifuge at 600–1000 × g for 10 min at 4 °C, and collect the supernatant.
• For serum/plasma: dilute as needed with assay buffer before use.

2. Standard Curve Preparation

• Dilute the provided Pyruvate Standard to prepare a series of standards spanning the linear detection range.
• Include a blank (assay buffer replacing sample) in every run.

3. Enzymatic Reaction

• Pipette the appropriate volume of sample (or standard) into labeled microtubes.
• Add Substrate Buffer and mix gently.
• Incubate at 37 °C for the time specified in the kit insert (refer to kit documentation for exact incubation duration).

4. Color Development

• Add the specified volume of DNPH Reagent to each tube and mix.
• Incubate at 37 °C for the time specified in the kit insert.
• Add NaOH Solution, mix thoroughly, and allow color to develop at room temperature for the time specified in the kit insert.

5. Absorbance Measurement

• Transfer reaction mixtures to a 96-well plate or cuvette.
• Measure absorbance at 440 nm against the blank.

6. Calculation

• Plot the standard curve (absorbance vs. pyruvate concentration).
• Derive sample pyruvate concentration from the standard curve.
• Calculate LDH activity using the formula provided in the kit documentation, normalizing to sample protein content (mg protein) or cell number as appropriate.

Troubleshooting and Tips

Low or No Signal:

• Ensure samples were not over-diluted; re-optimize dilution factor.
• Confirm that the substrate buffer contains active NAD⁺; avoid prolonged storage after reconstitution.
• Check that incubation temperature was maintained at 37 °C throughout the enzymatic step.
• Verify that DNPH reagent was added promptly after the enzymatic incubation.

High Background / Non-linear Standard Curve:

• Ensure all reagents are at room temperature before use (except samples).
• Check for contamination of sample with pyruvate-containing media or buffers, which can artificially elevate readings.
• Use freshly prepared DNPH reagent; aged or improperly stored DNPH may degrade.

Sample Interference:

• Hemolyzed blood samples contain high endogenous LDH and will give falsely elevated results; avoid hemolysis during blood collection.
• Strong reducing agents in sample lysis buffers may interfere with DNPH color development; test compatibility.

General Tips:

• Always run all samples and standards in duplicate or triplicate to improve data reliability.
• Normalize LDH activity to total protein content or cell number for meaningful inter-sample comparison.
• Keep all reagents on ice during the assay setup.

Data Interpretation and Reporting

Expressing LDH Activity: LDH activity is typically expressed as units per milligram of total protein (U/mg protein) or units per million cells (U/10⁶ cells), where one unit (U) represents the conversion of 1 µmol of substrate per minute under the defined assay conditions. Confirm the exact unit definition from the kit insert.

Cytotoxicity Assessment: When using LDH as a cytotoxicity marker, calculate the percentage LDH release relative to the maximum LDH release control (cells fully lysed with detergent) and a spontaneous release control (untreated cells). The formula is:

% Cytotoxicity = [(Experimental LDH release − Spontaneous release) / (Maximum release − Spontaneous release)] × 100

Interpreting Elevated LDH: Elevated LDH activity in culture supernatants or biological fluids reflects increased membrane permeability or cell death. In tissue samples, increased LDH can indicate ischemia, inflammation, or other pathological conditions.

Quality Control: Acceptable results require a coefficient of variation (CV) of less than 15% between replicates for standard curve points, and a linear R² ≥ 0.99 for the standard curve. Flag and re-run samples with readings outside the linear range after appropriate dilution.